AFP and hepatocellular carcinoma: Previously, a phase III biomarker study found that, for HCC detection, the GALAD algorithm showed an improvement in sensitivity but with a similar AUC compared with AFP-L3 alone, suggesting that AFP-L3 contributed to GALAD performance.16